Physician profile
Mark L Boles
NPI 1417969205
$2,096.31
in general payments reported to CMS, 2019-2025
23 companies · $414 in 2025
The $414 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $241 · 2021: $563 · 2022: $323 · 2023: $372 · 2024: $57.35 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $568.24 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Biogen, INC. | $251.93 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $241.33 | 2021-2025 | Veozah |
| Myovant Sciences INC. | $206.95 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $198.77 | 2021-2023 | |
| Hologic Sales and Service, LLC | $98.52 | 2022-2025 | Aptima, Acessa Provu System, Coolseal Generator |
| Evofem Biosciences, INC. | $81.51 | 2020-2022 | |
| Daiichi Sankyo INC. | $79.68 | 2019-2023 | Injectafer |
| Optumhealth Care Solutions, LLC | $47.95 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Pfizer INC. | $46.44 | 2024-2025 | |
| Minerva Surgical, INC | $32.10 | 2023 | |
| Sumitomo Pharma America, INC. | $30.90 | 2023-2024 | Gemtesa, Myfembree |
| Boston Scientific Corporation | $30.74 | 2019-2022 | |
| Davol INC. | $22.95 | 2023 | Arista Ah Flexitip |
| Allergan, INC. | $21.80 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $20.55 | 2023 | Quviviq |
| Vertex Pharmaceuticals Incorporated | $20.45 | 2025 | |
| Medline Industries LP | $18.59 | 2022 | |
| Therapeuticsmd, INC. | $17.80 | 2020 | |
| Organon LLC | $17.35 | 2023 | Nexplanon |
| Exeltis, USA INC. | $14.64 | 2025 | Slynd |
| Novo Nordisk INC | $13.73 | 2023 | Wegovy |
| Agile Therapeutics, INC. | $13.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Boles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.